生物活性
Tofacitinib (CP-690550,Tasocitinib)是一种新型JAK3抑制剂,IC50为1 nM,作用于JAK2和JAK1选择性低20到100倍。CP-690550 是特定的口服JAK3抑制剂, 作用于JAK2 和 JAK1,效果分别低20和100倍。CP-690550 对30种其他激酶没有作用效果,平均IC50 > 3000 nM。CP-690,550抑制IL-2诱导的增殖,比作用于GM-CSF诱导的增殖效果强30倍。
化学数据
分子量 |
312.37 |
分子式 |
C16H20N6O |
CAS号 |
477600-75-2 |
纯度 |
100.00% |
溶解性(25°C) |
DMSO ≥60 mg/mL |
储存和运输条件 |
-20°C, sealed 常温运输及临时存放 |
实验操作来自于公开的文献,仅供相同实验参考(如实验材料、目的不同,请参考其他文献)
细胞实验 |
细胞系 |
cytokine-dependent NK92 cell line |
方法 |
(A) After cytokine starvation for 24 hours, NK92 cells were stimulated by the addition of human IL-2 for 48 hours with and without the addition of serially increasing concentrations of tofacitinib. 3H-thymidine was added during the last 6 hours of the cultures. Cells were then harvested and analyzed for 3H-thymidine incorporation. (B) Cytokine-starved NK92 cells were stimulated with human IL-2, combined IL-6/IL- 6R, or IL-12 for 48 hours with and without serially increasing concentrations of tofacitinib. (C) The NK92 cells were treated as those in panel B with and without a single 50nM dose of tofacitinib. Data are presented as means ±SD (A-C) and are representative of 3 independent experiments. (D) After cytokine starvation for 24 hours, NK92 cells were stimulated with 30 ng/mL of IL-2, 100 ng/mL of combined IL-6/IL-6R, or 100 ng/mL of IL-12 for 1 hour with and without the addition of tofacitinib. The cell lysates were immunoblotted with an anti–phospho-STAT5 monoclonal antibody and an anti-STAT5 antibody. ss-Actin was used as an input control. Data are representative of 3 independent experiments. |
浓度 |
0~400 nM |
处理时间 |
48 h |
动物实验 |
动物模型 |
IL-15–transgenic CD8 T-cell leukemia–bearing mice |
配制 |
dissolved in polyethylene glycol 300 (PEG300; VWR Scientific Products) |
剂量 |
50 mg/mL |
给药处理 |
continuously administered via a subcutaneous mini-osmotic pump (ALZET) |
不同实验动物依据体表面积的等效剂量转换表(数据来源于FDA指南)
|
小鼠 |
大鼠 |
兔 |
豚鼠 |
仓鼠 |
狗 |
重量 (kg) |
0.02 |
0.15 |
1.8 |
0.4 |
0.08 |
10 |
体表面积 (m2) |
0.007 |
0.025 |
0.15 |
0.05 |
0.02 |
0.5 |
Km系数 |
3 |
6 |
12 |
8 |
5 |
20 |
动物 A (mg/kg) = 动物 B (mg/kg) × |
动物 B的Km系数 |
动物 A的Km系数 |
例如,依据体表面积折算法,将化合物用于小鼠的剂量20 mg/kg 换算成大鼠的剂量,需要将20 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到化合物用于大鼠的等效剂量为10 mg/kg。
储备液配制
以下数据基于半岛bd体育手机客户端 分子量,对于特殊半岛bd体育手机客户端 ,请参照COA中的储备液配制条件和说明进行操作。
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
3.2013 mL |
16.0067 mL |
32.0133 mL |
5 mM |
0.6403 mL |
3.2013 mL |
6.4027 mL |
10 mM |
0.3201 mL |
1.6007 mL |
3.2013 mL |